Enhabit Price to Book Ratio 2020-2024 | EHAB
Historical price to book ratio values for Enhabit (EHAB) over the last 10 years. The current price to book ratio for Enhabit as of May 07, 2025 is 0.75.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Enhabit Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-07 | 8.20 | 0.75 | |
| 2024-12-31 | 7.81 | $10.90 | 0.72 |
| 2024-09-30 | 7.90 | $11.79 | 0.67 |
| 2024-06-30 | 8.92 | $13.95 | 0.64 |
| 2024-03-31 | 11.65 | $13.94 | 0.84 |
| 2023-12-31 | 10.35 | $13.92 | 0.74 |
| 2023-09-30 | 11.25 | $14.05 | 0.80 |
| 2023-06-30 | 11.50 | $14.01 | 0.82 |
| 2023-03-31 | 13.91 | $15.39 | 0.90 |
| 2022-12-31 | 13.16 | $15.37 | 0.86 |
| 2022-09-30 | 14.04 | $17.41 | 0.81 |
| 2022-06-30 | 22.97 | $17.15 | 1.34 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.415B | $1.035B |
| Enhabit Inc. provides home health and hospice services. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration and skilled observation and assessment services; practices to treat chronic diseases and conditions. Enhabit Inc., formerly known as EHABIT INC, is based in Dallas, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $138.189B | 25.92 |
| Elevance Health (ELV) | United States | $94.312B | 12.17 |
| CVS Health (CVS) | United States | $84.478B | 10.50 |
| Cencora (COR) | United States | $59.063B | 20.54 |
| Natera (NTRA) | United States | $21.643B | 0.00 |
| DiDi Global (DIDIY) | China | $20.379B | 30.93 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.707B | 0.00 |
| Solventum (SOLV) | United States | $11.330B | 10.56 |
| ICON (ICLR) | Ireland | $11.213B | 10.42 |
| CochLear (CHEOY) | Australia | $11.158B | 0.00 |
| Doximity (DOCS) | United States | $10.895B | 56.66 |
| Revvity (RVTY) | United States | $10.796B | 18.58 |
| Viatris (VTRS) | United States | $10.198B | 3.25 |
| Medpace Holdings (MEDP) | United States | $8.622B | 22.90 |
| Sonic Healthcare (SKHHY) | Australia | $8.157B | 0.00 |
| Avantor (AVTR) | United States | $8.136B | 11.82 |
| HealthEquity (HQY) | United States | $7.933B | 39.03 |
| Charles River Laboratories (CRL) | United States | $6.727B | 13.18 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.028B | 23.75 |
| BrightSpring Health Services (BTSG) | United States | $4.015B | 37.16 |
| Sotera Health (SHC) | United States | $3.733B | 21.21 |
| Alignment Healthcare (ALHC) | United States | $3.071B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.969B | 34.06 |
| Concentras Parent (CON) | United States | $2.803B | 16.20 |
| Organon (OGN) | United States | $2.277B | 2.42 |
| Premier (PINC) | United States | $2.111B | 14.45 |
| Ardent Health Partners (ARDT) | United States | $2.028B | 8.66 |
| Progyny (PGNY) | United States | $2.006B | 44.19 |
| GeneDx Holdings (WGS) | United States | $1.609B | 63.01 |
| PACS (PACS) | United States | $1.603B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.454B | 27.07 |
| Agilon Health (AGL) | United States | $1.403B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.233B | 9.38 |
| Teladoc Health (TDOC) | United States | $1.203B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.960B | 0.00 | |
| CareDx (CDNA) | United States | $0.822B | 12.84 |
| AMN Healthcare Services Inc (AMN) | United States | $0.749B | 5.92 |
| Embecta (EMBC) | United States | $0.725B | 4.97 |
| QDM (QDMI) | Hong Kong, SAR China | $0.671B | 0.00 |
| Nutex Health (NUTX) | United States | $0.649B | 12.72 |
| Auna S.A (AUNA) | Luxembourg | $0.518B | 13.73 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.440B | 0.00 |
| LifeMD (LFMD) | United States | $0.364B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.347B | 0.00 |
| SBC Medicals (SBC) | United States | $0.332B | 0.00 |
| DocGo (DCGO) | United States | $0.245B | 10.00 |
| Oncology Institute (TOI) | United States | $0.208B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.179B | 0.00 |
| Beauty Health (SKIN) | United States | $0.178B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 6.75 |
| KindlyMD (KDLY) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |